ADaM defines dataset and metadata norms that support
• Effective generation
• Replication
• Review of clinical trial statistical analyses
• Traceable among analysis results, analysis & represented in the SDT Model.
As understood, ADaM is one of the required norms for data submission to FDA (USA) and PMDA (Japan). Details on the requirements for FDA are norms in the FDA’s Data Standard catalog for NDA, ANDA& certain BLA submissions
OTHER SERVICES
Biostatistics Services
Globally, the focus of the biopharmaceutical industry is on